Combination Chemotherapy for Influenza
The emergence of pandemic H1N1 influenza viruses in April 2009 and the continuous evolution of highly pathogenic H5N1 influenza viruses underscore the urgency of novel approaches to chemotherapy for human influenza infection. Anti-influenza drugs are currently limited to the neuraminidase inhibitors...
Main Authors: | Robert G. Webster, Elena A. Govorkova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/2/8/1510/ |
Similar Items
-
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
by: Chiara Medaglia, et al.
Published: (2021-06-01) -
Clinical and pharmacological approaches to present-day influenza anti-viral therapy
by: N. B. Lazareva, et al.
Published: (2018-04-01) -
Synthesis and Biological Evaluation of <i>NH</i><sub>2</sub>-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors
by: Yaping Hu, et al.
Published: (2019-06-01) -
Neuraminidase inhibitor use in adults presenting to hospital with suspected influenza: A questionnaire-based survey of practice among hospital physicians
by: Nathan J. Brendish, et al.
Published: (2021-07-01) -
NEURAMINIDASE INHIBITORS — THE GOLD STANDARD OF ANTIVIRAL INFLUENZA A THERAPY
by: V. V. TSVETKOV, et al.
Published: (2017-05-01)